RxDoctor Payments Data

Kenneth Ruiz

Surgical · New York, NYNPI 1407133515

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $77,040 of the $93,001 with a category attached, or 82.8%. AbbVie accounts for 98.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $72,419, more than ten times the $70 reported in 2021. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$93,001in general payments, 2019–2025

Across 258 payments — averaging $360.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$91K
  • Revance Therapeutics, Inc.$1K
  • Merz North America, Inc.$144
  • Baxter Healthcare$77
  • Cumberland Pharmaceuticals, Inc.$70
  • Galderma Laboratories, L.p.$33
  • plus $38 from 2 others

What the payments were for

  • Consulting fees$6701%
  • Speaking & faculty fees$77,04083%
  • Travel & lodging$8,3219%
  • Food & beverage$6,9717%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$93,001 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York

Other surgical in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →